Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies - Wikidata - awgldk - TriplyDB

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

http://www.wikidata.org/entity/Q28084055

about

Clinical features of limbic encephalitis with LGI1 antibody.Anti-N-Methyl-D-Aspartate Receptor Encephalitis in HIV Infection Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.CJD mimics and chameleons Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders.Optic Neuropathy As the Initial Presenting Sign of N-methyl-d-aspartate (NMDA) Encephalitis.Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey.Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future.Case report: pembrolizumab-induced Type 1 diabetes in a patient with metastatic cholangiocarcinoma.Autoimmune encephalitis associated with two antibodies.Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.Zelldepletion und Myeloablation bei neuroimmunologischen Erkrankungen

P2860

Q33825874-0A17535D-9D91-4B82-A234-F355B0D2EFE4 Q37562922-C2E242C9-0B32-4DD3-8FF5-F51122FB88F1 Q38729214-BC260921-3F97-4375-AD75-3A538E074E3D Q39116486-512E5E62-3A20-400C-AC15-BBA760C90676 Q39225440-2C49EDBE-9898-4A2B-9273-A7770144224B Q40276291-2A0FEEA9-D234-43A1-8360-BF97CF8EF019 Q40352626-8AE0B2BA-2025-479E-8DB5-F2B452D46AE5 Q43077236-2F9C4BB7-93F3-44F4-B4BD-5692F78C52FA Q47569563-45CBD89E-835F-4389-B8F8-A5D1746797FF Q55402320-6F87EAD0-B676-4B37-8159-143804A748F7 Q55456679-028D780D-7871-4D0F-84AD-DEED93EA0A1B Q57912843-BA0D8506-3537-4A94-BF95-59BA9ACF5431

P2860

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

http://www.wikidata.org/entity/Q28084055

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@ast

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@en

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@nl

type

label

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@ast

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@en

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@nl

prefLabel

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@ast

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@en

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@nl

P1433

Q28084055-30D968D7-FF36-4024-AE1F-AB0B55DB7B7B

P1476

Q28084055-EFA9DF27-3EBC-4F5A-84F0-A897DED50EE7

P2093

Q28084055-40F69E08-0A6E-43CA-9A18-1DF22348C5E3

Q28084055-50D6D4A1-A244-4110-BEF5-C8F312C8FFCC

P275

Q28084055-68FD8C3E-2EA2-4E2A-91C3-A4A3F1C48B2D

P2860

Q28084055-004DFDD7-FB36-451D-8D92-DFA98D2D6D99

Q28084055-01D184E4-B8FC-4055-8408-CB7D6CE21663

Q28084055-0731974A-6583-4498-8D47-4434D7E51A51

Q28084055-0D59E188-28C4-4A40-8B03-D15CA118F746

Q28084055-0DB6BDED-AE5E-4F7D-89D0-C6592B19861D

Q28084055-124D6B8A-D12A-4874-88C6-F65879C93B09

Q28084055-162DA9C1-32E1-48F3-ADCF-30219FB59F3B

Q28084055-1A76586E-BCD2-49E7-99C7-B1EB1399550B

Q28084055-1B791194-D87C-4741-9E6D-EAD765761CB0

Q28084055-1BC7EB37-8535-4A4C-A18F-06D3C73232E1

P2888

Q28084055-2224513F-2FB4-4CC1-80E6-56496835D068

P304

Q28084055-101E1476-4EC9-48C1-9F22-025BDF0B0D04

P31

Q28084055-15679CA3-F346-43ED-8989-9A2FA37EB515

Q28084055-A4FA3710-73F5-4D00-9E49-60AED124D74A

P356

Q28084055-455BB983-18F5-4E90-AB63-2D8C103D20D0

P407

Q28084055-053A7ADE-1251-4E20-AA08-3BA0310089CE

P433

Q28084055-CC230217-9F52-4885-B644-9DBA70529CE8

P478

Q28084055-64E40493-FB68-4225-B0C6-BC54A3F28E10

P50

Q28084055-643DE405-2034-4B50-ABF4-4E96BC558D33

P5008

Q28084055-CBFF1684-C288-4B44-BC91-5E135F73BCFD

P577

Q28084055-6354B968-992F-4C48-94B6-6D8906F757B1

Q28084055-B1ADE25C-732B-4C71-BB51-2C865958BD86

P5875

Q28084055-0567A10E-3B63-4FC8-BE33-54E3A04D8D5A

P698

Q28084055-4297356D-E59B-493C-BB62-1F267DBC9E75

P921

Q28084055-11A409FE-AC87-4889-8598-32E2E26A9FDA

Q28084055-4DFCEDAA-ACAA-4865-951C-B542A3034DE1

Q28084055-EBB0FCDE-2333-4EFC-992D-495D54991C60

Q28084055-F355739C-5219-4968-9123-A14F98BB56E4

Q28084055-F4775E9A-E87F-4A93-9408-9327A78CEBCB

P932

Q28084055-9A973385-26B6-4DB8-910B-BAE1BED6A019

P356

S13311-015-0410-6

P1433

Neurotherapeutics

P1476

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

@en

P2093

Anaïs Thouin

http://www.w3.org/2001/XMLSchema#string

Matteo Gastaldi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.

Potassium channel antibodies in two patients with reversible limbic encephalitis

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

P2888

s13311-015-0410-6

P304

147-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-015-0410-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287806901

http://www.w3.org/2001/XMLSchema#string

P698

26692392

http://www.w3.org/2001/XMLSchema#string

P921

autoimmune disease of the nervous system

P932

4720680

http://www.w3.org/2001/XMLSchema#string